Related Experiment Video
Updated: Jul 28, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Abnormal glucose levels found in transportation accidents
D V Canfield1, A K Chaturvedi, H K Boren
1Civil Aerospace Medical Institute, Federal Aviation Administration, Oklahoma City, OK, USA. dennis_canfield@mmacmail.jccbi.gov
Aviation, Space, and Environmental Medicine
|September 22, 2001
Summary
Postmortem vitreous humor and urine glucose levels can indicate pre-existing diabetic conditions in aviation accident fatalities. This analysis aids in identifying potential medical factors contributing to accidents.
Area of Science:
- Forensic Toxicology
- Aviation Medicine
- Diabetic Condition Assessment
Background:
- The Federal Aviation Administration (FAA) certifies pilots with diabetes.
- Assessing postmortem glucose levels in accident fatalities is crucial for identifying incapacitating medical conditions.
Purpose of the Study:
- To evaluate postmortem vitreous humor and urine glucose levels as indicators of medical impairment.
- To determine the utility of these biomarkers in aviation accident investigations.
Main Methods:
- Analyzed vitreous humor and urine glucose in 192 accident fatalities using the hexokinase method.
- Excluded values below detection limits or extreme outliers (above 3 SD).
- Identified abnormal glucose levels and reviewed medical histories for cases exceeding 5 SD.
Main Results:
- Mean vitreous humor glucose: 30±21 mg/dL (N=98); Mean urine glucose: 27±16 mg/dL (N=127).
- Nine cases showed abnormal glucose levels, including 5 of 8 known diabetic individuals.
- Two pilots had glycosuria; one had abnormal glucose levels.
Conclusions:
- Postmortem vitreous humor and urine glucose levels effectively indicate hyperglycemia.
- Abnormal glucose findings correlated with pre-existing diabetic conditions or other medical reasons.
- Elevated glucose levels are valuable in identifying diabetic conditions as potential accident factors.
Related Concept Videos
Glucose Transporters
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...

